Searchable abstracts of presentations at key conferences in endocrinology

ea0090p782 | Thyroid | ECE2023

The impact of lockdown on thyroid hormone metabolism in patients on levothyroxine replacement therapy residing in Adjara

Jashi Liana , Peshkova Tamar , Dundua Ketevan , Kamashidze Koba , Kvanchakhadze Rusudan , Beridze Sophio

Background: The Covid 19 pandemic has significantly changed people’s lives. For patients with chronic diseases, social isolation and distancing have become a provocative factor in metabolic control disorders of varying degrees. Patients avoided hospital visits as much as possible due to fear of infection. Also for the representatives of the medical field, the pandemic has become the basis for new ways of consulting patients (remote, teleconsultation). The aim of the study...

ea0099ep1211 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Psychological effects of gpp-1 agonists in the treatment of young overweight patients with type 2 diabetes mellitus (clinical case)

Jashi Liana , Peshkova Tamar , Sharashenidze Tamar , Dundua Ketevan , shervashidze tamar , Beridze Sophio

Background: Patient: male, 34 years old, height 32.4 cm (height 182 cm, weight 118 kg), heredity not severe, history of cholecystectomy, depressive background, takes Solian and Lemonex. Bad habits - smokes tobacco, does not drink alcohol. Covid 19 in 2021, vaccinated with 2 doses of Pfizer-BioNTech vaccine. 2023 In May, he was hospitalized with hyperglycemia, where insulin therapy was started: Apidra - 9 00 - 16IU 1400 – 14IU 1900 - 12 IU,...

ea0029p1324 | Paediatric endocrinology | ICEECE2012

Newborn screening for congenital hypothyreoidism(CH) in Georgia

Beridze N. , Takaishvili R. , Azikuri T. , Mumladze M. , Iashvili M.

Background and aim: Revelation of the incidence of CH is of great value at the background of iodine deficiency (ID) existing in Georgia. Screening on CH in our company with consequent monitoring of the newborns with neonatal hyperthyreotropinemia (NHT) started in September 2010.Materials and methods: During the first year period 70 731 newborns from all over Georgia underwent TSH (mU/l) determination from blood spots, taken at 24–72 h after birth an...

ea0011p424 | Diabetes, metabolism and cardiovascular | ECE2006

Left ventricular geometry and contractile ability in type 2 diabetes and non-diabetic patients with mild hypertension

Beridze N , Bochorishvili I , Iashvili M , Kurashvili R , Dundua M

The aim: To reveal relation between altered left ventricular (LV) geometry (G) and contractile ability (CA) in nonbese type 2 diabetic (DM2) patients with mild hypertension (MH).Materials and methods: BP at rest, 24-h ambulatory BP monitoring and echocardiography were investigated in 70 non-obese males, aged 25–50 yrs. They were divided into the following groups: Gr.1, n=15 – DM2 and normal BP, fasting C-peptide (C-p, ng/ml) 4.3±0.9...

ea0099ep892 | Pituitary and Neuroendocrinology | ECE2024

Cardiac arrest as a presentation of hypophysitis-induced hypopituitarism developed following a COVID-19 infection

Tedoradze Nino , Pailodze Mariam , Kobaidze Ann , Davitadze Meri , Tsikarishvili Sophio , Akiashvili Nino , Jajanidze Lika

Background: Hypophysitis is a rare inflammatory condition of the pituitary gland, speculated to have autoimmune aetiology. The diverse clinical presentations rely on hormonal deficiencies and the pathophysiological impact on the target organs. This condition may give rise to life-threatening complications. MRI is the best imaging modality for diagnosis and the conclusive diagnosis necessitates a biopsy of the affected tissue. The optimal management approach remains a subject o...

ea0058dp1.3 | Diabetes Professionals Day: Session 1 | BSPED2018

Optimising transition in young adults with diabetes

Skelding Rebecca , Salahuddin Sophia

An MDT approach to facilitating a workable transition between paediatric and adult services for young people with T1 and T2 diabetes. Management of young people with T2 diabetes is an emerging field that provides new challenges to the healthcare team in enabling young people to live with a lifelong condition that may also be affecting the wider family. Our service is delivered across two sites looking after young people with diabetes aged between 14–19 years in paediatric...

ea0056p1201 | Thyroid cancer | ECE2018

Serum TSH levels as a predictor of thyroid cancer

Novosad Sophia , Martirosyan Narine

Background: The aim of our study is to show the evaluate relationship between cytological feature of thyroid nodule and TSH level.Objective: To retrospectively evaluate the usefulness of serum TSH levels as a predictor of thyroid cancer.Methods: Patients with thyroid nodule(s) who underwent fine-needle aspiration biopsy under ultrasonographic guidance in a Clinica of Administration of the President of the RF were consecutively eval...

ea0094p32 | Bone and Calcium | SFEBES2023

Review of current guidelines on fracture risk recommendations in patients on hormonal therapies for Breast Cancer

Busch Sophia , Higham Claire

Introduction: Women prescribed hormonal therapies for breast cancer (eg Aromatase Inhibitors (AI) and ovarian suppression therapy (OST)) are at increased risk of fracture and monitoring of Bone Mineral Density (BMD) is needed. Recommendations for BMD monitoring and treatment interval thresholds differ between guidelines which has implications for management. We compared the outcomes from the application of 3 commonly used guidelines for bone health in women wi...

ea0099ep1143 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Metabolic regulation of adipose stem cell fate and function: from bench to clinic

Pollard Alice , Bustraan Sophia

White adipose tissue is a vital endocrine organ required for the storage of energy in the form of triglycerides, which is released in response to nutrient deprivation, and for the production of hormones such as leptin and adiponectin. In this way, adipose tissue is at the forefront of whole organism energy homeostasis. Adipose tissue dysfunction is associated with many metabolic diseases including T2D, cardiovascular disease and non-alcoholic fatty liver disease (NAFLD). Adipo...

ea0049d5.2 | Should we still ablate all patients undergoing total thyroidectomy for thyroid cancer? | ECE2017

Should we still ablate all patients undergoing total thyroidectomy for thyroid cancer? - AGAINST

Leboulleux Sophie

Regarding the debate about whether we should still ablate all patients undergoing total thyroidectomy, the answer is no. Most thyroid cancer patients have an excellent prognosis with a normal life expectancy and among them most of them have a low risk of recurrence. The absence of ablation in patients with thyroid cancer of 1 centimeter or less (pT1a) is already widely applied, so, we are used not to ablate all thyroid cancer patients treated with total thyroidectomy. The ques...